ORIGINAL RESEARCH ARTICLE

Clinical profile comparison of cisatracurium and rocuronium in elective surgery

Reema Meena, Priyanka Jain , Divya Rana, Indu Verma, Sunil Chauhan

Reema Meena
Sawai Man Singh Medical College , Jaipur,Rajasthan ,India

Priyanka Jain
. Email: Dr.divyarana91@gmail.com

Divya Rana


Indu Verma


Sunil Chauhan

Online First: August 30, 2019 | Cite this Article
Meena, R., Jain, P., Rana, D., Verma, I., Chauhan, S. 2019. Clinical profile comparison of cisatracurium and rocuronium in elective surgery. Bali Journal of Anesthesiology 3(2). DOI:10.15562/bjoa.v3i2.140


Background:  Most surgeries are carried out with ease using neuromuscular blocking agents. This study was aimed to compare the intubating dose of cisatracurium and rocuronium regarding the onset of action, clinical duration, recovery index, intubating conditions, efficacy, and safety in elective surgery.

Method: 60 adult patients of American Society Anesthesiology (ASA) grade I & II, underwent elective laparoscopic surgery were randomized to receive either cisatracurium 0.1 mg/kg (Group C) or rocuronium 0.6 mg/kg (Group R). Neuromuscular monitoring was done using STIMPOD Xavant NMS450. Relaxogram interpretation was carried out for the onset of action, clinical duration, and recovery index.

Results: Cisatracurium had significant longer onset (233.33±62.31 vs. 86.66±28.62 seconds, p <0.001) and significant longer clinical duration (40±3.56 vs. 27.46±2.14 minutes, p <0.001) than rocuronium. Recovery index was significantly longer in the cisatracurium group (12.23±1.54 vs. 8.30±1.80 minutes, p <0.001). Clinically acceptable intubating conditions were achieved in 180 seconds (C group) compared to 60 seconds in the R group. No untoward or adverse response and complications were distinguished in either group.

Conclusion: Cisatracurium 0.1 mg/kg exhibited a slower onset of action than rocuronium 0.6 mg/kg and provided excellent intubating conditions in the majority of patients after 180 seconds. The clinical duration and recovery index were significantly longer in cisatracurium compared to rocuronium. Both are potent and safe agents with excellent cardiovascular stability.

References

Ghorbanlo M, Mohaghegh MR, Yazdanian F, Mesbah M, Totonchi Z. A Comparison Between the Hemodynamic Effects of Cisatracurium and Atracurium in Patient with Low Function of Left Ventricle who are Candidate for Open Heart Surgery. Med Arch. 2016;70(4):265-8. doi:10.5455/medarh.2016.70.265-268.

Kim YB, Sung TY, Yang HS. Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents. Korean J Anesthesiol. 2017;70(5):500-10. doi:10.4097/kjae.2017.70.5.500.

Xiaobo F, Jianjuan K, Yanlin W. Comparison of the variability of the onset and recovery from neuromuscular blockade with cisatracurium versus rocuronium in elderly patients under total intravenous anesthesia. Braz J Med Biol Res. 2012;45(7):676-80. doi:10.1590/s0100-879x2012007500076.

Hidayat J, Marsaban A, Daryono M. Effectiveness of Partial and Adjustment Neostigmine Dose as a Neuromuscular Reversal for Single Dose Rocuronium. Bali Journal of Anesthesiology. 2018;2(1):10-6. doi:10.15562/bjoa.v2i1.62.

Omera M, Hammad YM, Helmy AM. Rocuronium versus Cisatracurium: onset of action, intubating conditions, efficacy, and safety. Alexandria Journal of Anaesthesia and Intensive Care. 2005;8(2):27-33.

Park WY, Choi JC, Yun HJ, Jeon YG, Park G, Choi JB. Optimal dose of combined rocuronium and cisatracurium during minor surgery: A randomized trial. Medicine (Baltimore). 2018;97(10):e9779. doi:10.1097/MD.0000000000009779.

Hemmerling TM, Donati F. Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review. Can J Anaesth. 2003;50(8):779-94.

Lee H, Jeong S, Choi C, Jeong H, Lee S, Jeong S. Anesthesiologist's satisfaction using between cisatracurium and rocuronium for the intubation in the anesthesia induced by remifentanil and propofol. Korean J Anesthesiol. 2013;64(1):34-9. doi:10.4097/kjae.2013.64.1.34.

Carroll MT, Mirakhur RK, Lowry DW, McCourt KC, Kerr C. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants. Anaesthesia. 1998;53(12):1169-73.

Kim KS, Chung CW, Shin WJ. Cisatracurium neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans. Br J Anaesth. 1999;83(3):483-4.

Hofmockel R, Benad G, Kabott A. Mechanomyographic and electromyographic studies of endotracheal intubation with 2 different rocuronium dosages. Anaesthesiol Reanim. 1994;19(6):144-8.

Pühringer FK, Khuenl-Brady KS, Koller J, Mitterschiffthaler G. Evaluation of the endotracheal intubating conditions of rocuronium (ORG 9426) and succinylcholine in outpatient surgery. Anesth Analg. 1992;75(1):37-40.

Lepage JY, Malinovsky JM, Malinge M, et al. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia. Anesth Analg. 1996;83(4):823-9.

Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg. 1998;87(4):936-40.

Chetty MS, Pollard BL, Wilson A, Healy TE. Rocuronium bromide in dental day case anaesthesia--a comparison with atracurium and vecuronium. Anaesth Intensive Care. 1996;24(1):37-41.

Neal SM, Manthri PR, Gadiyar V, Wildsmith JA. Histaminoid reactions associated with rocuronium. Br J Anaesth. 2000;84(1):108-11.


No Supplementary Material available for this article.
Article Views      : 37
PDF Downloads : 18